Endurant Capital Management’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-144,393
Closed -$4.25M 66
2021
Q2
$4.25M Buy
144,393
+2,070
+1% +$61K 1.17% 34
2021
Q1
$3.92M Buy
+142,323
New +$3.92M 1.02% 35
2020
Q4
Sell
-111,467
Closed -$2.68M 76
2020
Q3
$2.68M Sell
111,467
-48,751
-30% -$1.17M 0.79% 33
2020
Q2
$3.72M Buy
+160,218
New +$3.72M 0.2% 27